Holen Sie sich die Stockscreener-App
4.11
4.20%
-0.18
Schlusskurs vom Vortag:
$4.29
Offen:
$4.2
24-Stunden-Volumen:
147.74K
Relative Volume:
0.08
Marktkapitalisierung:
$11.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.69M
KGV:
-1.7639
EPS:
-2.33
Netto-Cashflow:
$-3.81M
1W Leistung:
+1.23%
1M Leistung:
+427.60%
6M Leistung:
+70.95%
1J Leistung:
+71.25%
1-Tages-Spanne:
$3.90
$4.35
1-Wochen-Bereich:
$3.82
$4.35
52-Wochen-Spanne:
$0.64
$4.45
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Firmenname
Lixte Biotechnology Holdings Inc
Sektor
Branche
Telefon
310 203 2902
Adresse
248 ROUTE 25A, EAST SETAUKET
Vergleichen Sie LIXT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.11 | 12.99M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten
Lixte Biotechnology Holdings Inc. Equity Warrant Stock Analysis and ForecastExceptional portfolio growth - PrintWeekIndia
Does Lixte Biotechnology Holdings Inc. stock pay reliable dividendsFree Market Volatility Navigation Tips - jammulinksnews.com
What drives Lixte Biotechnology Holdings Inc. Equity Warrant stock priceConsistent triple-digit returns - Autocar Professional
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionMarket Trend Watch - Newser
What analysts say about Lixte Biotechnology Holdings Inc. stockFree Trading Strategy Suggestions - PrintWeekIndia
What analysts say about Lixte Biotechnology Holdings Inc. Equity Warrant stockHigh-octane gains - Autocar Professional
Is Lixte Biotechnology Holdings Inc. Equity Warrant a good long term investmentFree Bull & Bear Market Updates - jammulinksnews.com
What drives Lixte Biotechnology Holdings Inc. stock priceFree Technical Analysis Support - jammulinksnews.com
LIXT adds 2 directors after Series B deal; CMO resigns, board reshuffle | LIXTW SEC FilingForm 8-K - Stock Titan
Lixte Biotechnology Holdings Inc. Stock Analysis and ForecastStrongest growth potential - Autocar Professional
Is Lixte Biotechnology Holdings Inc. a good long term investmentAccelerated investment success - jammulinksnews.com
Published on: 2025-07-19 22:24:49 - jammulinksnews.com
LIXTE Biotechnology regains Nasdaq compliance - MSN
Lixte Biotechnology shares fall 2.38% premarket after regaining Nasdaq compliance. - AInvest
Fluence Energy's Price Target Raised by Barclays: A Shift in Market Dynamics? - AInvest
LIXTE Biotechnology Regains Nasdaq Listing Compliance with $5 Million Financing - AInvest
What analysts say about Lixte Biotechnology Holdings Inc. stock outlookRapid Gain Targets - Newser
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising - The Globe and Mail
Lixte Biotechnology shares fall 3.23% premarket after closing a $5 million private placement. - AInvest
LIXTE Biotechnology Regains Nasdaq Compliance with $5M Financing - AInvest
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyFree Consultation - beatles.ru
LIXTE Biotechnology Meets Nasdaq Listing Requirement, Shares Down - AInvest
LIXTE Biotechnology's Compliance Win: A Turning Point for Clinical Gains and Stock Stability? - AInvest
LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital Raise - Nasdaq
LIXTE Biotechnology regains Nasdaq compliance after $5M funding. - AInvest
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements - GlobeNewswire
LIXTE Biotechnology Holdings Regains Nasdaq Listing Compliance with New Financing - AInvest
LIXTE Secures $6.5M Funding, Maintains Nasdaq Listing While Advancing Cancer Drug Trials - Stock Titan
How Lixte Biotechnology Holdings Inc. Equity Warrant stock performs during market volatility - Newser
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyFree Stock Selection - Newser
How Lixte Biotechnology Holdings Inc. stock performs during market volatilityBreakout Level Watch - Newser
Finanzdaten der Lixte Biotechnology Holdings Inc-Aktie (LIXT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):